Cite Filings / IRWD / 0001172661-25-001312
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
SCHEDULE 13G/A

Statement of Beneficial Ownership

IRONWOOD PHARMACEUTICALS INC · Filed 2025-02-14 · Acc 0001172661-25-001312

Documents 1

  • SCHEDULE 13G/A Statement of Beneficial Ownership , xslSCHEDULE_13G_X01/primary_doc.xml

Around this filing

  • 2025-03-07 SCHEDULE 13G/A Statement of Beneficial Ownership
  • 2025-02-14 SCHEDULE 13G/A Statement of Beneficial Ownership
  • 2025-02-12 4 Chief Executive Officer sold 139,064 shares at $1.76 ($244,753)
  • 2025-02-12 4 Principal Accounting Officer sold 12,048 shares at $1.76 ($21,204)
  • 2025-02-12 4 Chief Legal Officer sold 38,938 shares at $1.76 ($68,531)
  • 2025-02-12 4 Chief Financial Officer sold 12,052 shares at $1.76 ($21,212)
  • 2025-01-31 SCHEDULE 13G/A Statement of Beneficial Ownership

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading xslSCHEDULE_13G_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…